2020 BIO CEO & Investor Conference Attendee List

[Pages:18]2020 BIO CEO & Investor Conference Attendee List

as of January 29, 2020

TITLE/INVESTOR TYPE VC/Corporate VC Family Office Family Office Founder and Chair Director VC/Corporate VC VC/Corporate VC Executive Vice President, Chief Business Officer VC/Corporate VC Principal Financial Officer Chairman and CEO Family Office VC/Corporate VC VC/Corporate VC CEO Hedge/Mutual Funds (PM, Buy-Side Research) Family Office CEO VC/Corporate VC CEO VC/Corporate VC CEO Family Office Associate Head of LaunchLabs Family Office Investor Venture Philanthropy Angel Investing SVP, Head of Medical Affairs Chief Executive Officer Chairman VP of Business Development Chief Financial Officer President and CEO Chief Scientific Officer PRESIDENT/CEO CEO President

COMPANY 3E Bioventures 3i Fund A C Binder Corp Ab Studio AbbVie Accelmed Partners Aceras Partners Achillion Pharmaceuticals Acorn Bioventures Actinium Pharmaceuticals Actinium Pharmaceuticals Acuitas Capital Family Office Aditum Bio Adjuvant Capital Aetion Affinity Asset Advisors AFUND Ai Cure Technologies AIG AIMM Therapeutics Aisling Capital AiVita Biomedical Aleph Capital Alexandria Venture Investments Alexandria Venture Investments Alignment Ventures Alliance for Aging Research Alliance for Cancer Gene Therapy Alnitak capital Alnylam Pharmaceuticals Alpha Cancer Technologies Alpha Cancer Technologies Alpine Immune Sciences Altimmune Altimmune Altimmune ALTuCELL Alveo Technologies Alveo Technologies

COUNTRY United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States Netherlands United States United States United States United States United States United States United States United States United States United States Canada Canada United States United States United States United States United States United States United States

Chief Executive Officer CEO Founder and Chief Science Officer VC/Corporate VC President & CEO CEO Chief Executive Officer Investor President & CEO Founder and CBO Co-founder and CEO Hedge/Mutual Funds (PM, Buy-Side Research) Vice President Account Executive Investment Officer CEO President and Executive Director Senior Associate Head of Research & Development Chief Financial Officer Chairman & CEO Chief Business Officer CFO Family Office CEO VC/Corporate VC Founder, President & CEO Director, IR/PR/Marketing President and Chief Executive Officer VC/Corporate VC CEO Hedge/Mutual Funds (PM, Buy-Side Research) Royalty/Debt Financing CEO Chief Business Officer CEO Sell-Side Research Investment Bank Hedge/Mutual Funds (PM, Buy-Side Research) Chief Business Officer Chairman, CEO & President Founder/CEO Hedge/Mutual Funds (PM, Buy-Side Research) VC/Corporate VC VC/Corporate VC Angel Investing VC/Corporate VC

American Gene Technologies International AMNICELL AMNICELL Amplitude Ventures Amplyx Pharmaceuticals Amygdala Neurosciences Anavex Life Sciences Andreessen Horowitz AnGes Inc. AnHeart Therapeutics Anima Biotech Anson Funds Aon Risk Solutions Aon Risk Solutions Apex-Brasil Aprinoia Therapeutics Aptorum Group Aptorum Group Aptorum Group Aptose Biosciences Aptose Biosciences Aptose Biosciences Aracari Biosciences Aracle Capital Arch Biopartners Arch Venture Partners Arcturus Therapeutics Arcturus Therapeutics Arena Pharmaceuticals Arix Bioscience ARJUNA Therapeutics Armistice Capital Arsenal Capital Partners Aruvant Sciences, Inc. Ascendia Pharmaceuticals Ascendia Pharmaceuticals Ascendiant Capital Markets Ascendiant Capital Markets Ashford Capital Management Ashvattha Therapeutics Ashvattha Therapeutics Asimov Aspire Capital Asset Management Ventures Astellas Pharma US Astute Capital ATEM Capital

United States United States United States Canada United States United States United States United States Japan United States United States Canada United States United States Brazil Taiwan Hong Kong Hong Kong Hong Kong United States United States United States United States United States Canada United States United States United States United States United States Spain United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States

VC/Corporate VC CFO and GC Chief Financial Officer IR Chief Strategy Officer Chief Financial Officer President, CEO Royalty/Debt Financing Investor Managing Director, LS Client Solutions Head, Client Solutions President and CEO Hedge/Mutual Funds (PM, Buy-Side Research) President and CEO Chief Operating and Business Officer Director, Business Development VC/Corporate VC Financial Advising Investor Hedge/Mutual Funds (PM, Buy-Side Research) Family Office COO Investment Bank Senior Manager/Area Manager UK Hedge/Mutual Funds (PM, Buy-Side Research) Family Office Family Office VC/Corporate VC CEO Corporate Account Manager President & CEO Investor Angel Investing Angel Investing Hedge/Mutual Funds (PM, Buy-Side Research) Senior Membership and BD Manager VC/Corporate VC VP Research and Development CEO President & CEO Hedge/Mutual Funds (PM, Buy-Side Research) VC/Corporate VC Angel Investing Family Office Family Office CEO and Co-founder Family Office

Atheneos Ventures Atossa Genetics Atreca Atreca Atreca aTyr Pharma aTyr Pharma AUGC Aurora Capitals Avalere Health Avalere Health Avenue Therapeutics Ayrton Capital Azitra AZTherapies AZTherapies Baidu Bank of America Merrill Lynch Barclays Bathala Capital Beacon Capital Beacon Pharmaceutical Berenberg Capital Markets

Berlin Partner f?r Wirtschaft und Technologie GmbH

Bifrost Capital Bigger Capital Fund BIMA Capital Bioadvance Bioasis Technologies BioCentury Biocept Biocoast Capital BioIDEA BioIdeations BioIdeations Bioindustry Association (BIA) BioInnovation Capital BioLineRx BioLineRx BioMarker Strategies Biondo Investment Advisors Bios Partners BioSense Global Biotech Alliances International Biotech Investment Group BioVersys AG Black Diamond Advisors

United States United States United States United States United States United States United States Netherlands United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States Germany United States United States United States United States United States United States United States United States United States United States United States United Kingdom United States Israel Israel United States United States United States United States United States United States Switzerland United States

Senior Health-Care Policy Analyst Hedge/Mutual Funds (PM, Buy-Side Research) Angel Investing VC/Corporate VC CEO VC/Corporate VC Chief Operating Officer & Chief Medical Officer President & CEO Chief Executive Officer Business Development Account Executive Investment Bank Royalty/Debt Financing Associate Director, External Operations

VP, Hematology, Cell Therapy & Translational Medicine

Angel Investing Sell-Side Research Sell-Side Research Sell-Side Research Venture Partner President & CEO Vice President of IR & Corporate Communications President & CEO Sell-Side Research Chief Executive Officer Sell-Side Research Investor

Director, Advanced Therapy Medicinal Product Development

Chairman & CEO COO & CSO Bussiness developer President Family Office Family Office managing director Executive Vice President & Chief Scientific Officer VP Technology CEO/President Chief Executive Officer Chief Executive Officer Public Relations Contact Chief Executive Officer Partner CEO CEO CEO Angel Investing

Bloomberg Intelligence Blue Rock Capital Advisors Bohe Angel Fund Bojian Capital Boundless Bio Brace Pharma Capital BrainStorm Cell Therapeutics BrainStorm Cell Therapeutics Breakthrough Genomics Brex Brex Bridge Bank Bridge Bank Bristol-Myers Squibb Bristol-Myers Squibb Brock Capital Group Brookline Capital Markets Bryan, Garnier & Co. BTIG BVCF Caladrius Biosciences Caladrius Biosciences California Life Sciences Association Canaccord Genuity Cancer Prevention Pharmaceuticals Cantor Capital Family Office Cardinal Health Catalyst Pharmaceuticals Catalyst Pharmaceuticals Catalyze NA Catalyze NA Cato BioVentures Caxton Alternative Management Cedrus Group Celavie Biosciences Celavie Biosciences Celavie Biosciences Cell Care Therapeutics Celmatix Cel-Sci CEL-SCI Centerview Partners Cerevance Cernostics CerSci Therapeutics Chaperone Investment

United States United States China United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States Netherlands Netherlands United States United States Hong Kong United States United States United States United States United States United States United States United States United States United States United States United States

Sell-Side Research Family Office Hedge/Mutual Funds (PM, Buy-Side Research) Chief Executive Officer Family Office Life Sciences Underwriter Investor Hedge/Mutual Funds (PM, Buy-Side Research) Chief Executive Officer VC/Corporate VC Director President & CEO Director, Investor Relations Chief Operating Officer CEO Co-Founder and CSO Commercial Attach? of Lithuania to the USA President VC/Corporate VC Angel Investing Hedge/Mutual Funds (PM, Buy-Side Research) CEO / CMO CFO VC/Corporate VC Investor Investor VC/Corporate VC VC/Corporate VC Angel Investing President & CEO Executive Vice President, Finance & COO President & CEO Chief Executive Officer CEO VP Corporate Affairs Chairman & CEO Chief Executive Officer Investor President & CEO Investor VC/Corporate VC CEO Chief Business Officer VP, Business Development VC/Corporate VC Angel Investing Venture Philanthropy

Chardan Capital Markets Charlestown Capital Chartwell ChemioCare Chronon Capital Chubb Church Pension Fund CJ Seligman & Co. Clearside Biomedical CLI Clinical Network Services CODA Biotherapeutics CohBar CohBar CohBar Inc. Concarlo Holdings Consulate General of Lithuania Correlia Biosystems Cowen Healthcare Investments Cowin Venture Crescent Capital Ventures Cristal Therapeutics Cristal Therapeutics Crosswave Management CRV CSC Leasing CTI Capital Gestion CTTQ Pharmaceutical Group CyberMed Holdings Cybrexa Therapeutics Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals Cytodel Cytonus Therapeutics Cytovia Therapeutics Cytovia Therapeutics Da Volterra Dabar Investment Associates Dar? Bioscience DB Capital Deca Ventures DeckTherapeutics Decoy Biosystems Deerfield Management Company Deerfield Management Company DEFTA Partners Delaware Innovation Space

United States United States United States United States United States United States United States United States United States United States United Kingdom United States United States United States United States United States United States United States United States China United States Netherlands Netherlands United States United States United States United States United States United States United States United Kingdom United States United States United States United States United States France United States United States United States United States United States United States United States United States United States United States

President and CEO Investment Bank Hedge/Mutual Funds (PM, Buy-Side Research) Sell-Side Research VC/Corporate VC Hedge/Mutual Funds (PM, Buy-Side Research) Hedge/Mutual Funds (PM, Buy-Side Research) CEO Family Office Chief Executive Officer Chief Commercial Officer VC/Corporate VC CEO / Co-Founder Chief Operating Officer Family Office VC/Corporate VC Hedge/Mutual Funds (PM, Buy-Side Research) President and CEO VC/Corporate VC CEO Vice President, Emerging Technology & Innovation Sr. Director, Search & Evaluation - Immunology Advisor, Search & Evaluation - Oncology Director, Business Development Chief Business Officer CEO President, Co-founder and Chief Scientific Officer Investor Relations Chief Executive Officer President, CEO & Founder Executive Vice President and Chief Operating Officer Chief Scientific Officer President and CEO Hedge/Mutual Funds (PM, Buy-Side Research) CEO Chief Executive Officer CEO Chief Executive Officer Family Office Chief Executive Officer VC/Corporate VC CEO Sell-Side Research CEO CEO Angel Investing Family Office

DelMar Pharmaceuticals Deltec Bank Delwar Capital Management Deutsche Bank DHVC District 2 Capital Douglas C. Lane & Associates Drusolv Therapeutics DTB Capital Management Dyadic International Dyadic International Dynamk Capital Dyve Biosciences Dyve Biosciences E Squared Capital Management Easton Capital Edgewood Management eFFECTOR Therapeutics EG Capital Advisors Eleusis Eli Lilly and Company Eli Lilly and Company Eli Lilly and Company Eloxx Pharmaceuticals Eloxx Pharmaceuticals Emerald Bioscience ENB Therapeutics Encore Advisory Enesi Pharma Engage Therapeutics Engage Therapeutics Engrail Therapeutics Engrail Therapeutics Ensconce Capital Envisagenics EpicentRx EpiVax Oncology Equillium Esousa Holdings E-Therapeutics ETP Global Fund Eupraxia Pharmaceuticals EVOLUTION Life Science Partners Evonetix EVQLV Executive Forum Angels Exome Asset Management

United States Bahamas United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States Russian Federation United States United States United States United States United States United States United States United States United States United Kingdom United States United States United States United States United States United States United States United States United States United States United Kingdom United States Canada United States United Kingdom United States United States United States

President & CEO Chief Financial Officer VC/Corporate VC Family Office Hedge/Mutual Funds (PM, Buy-Side Research) Hedge/Mutual Funds (PM, Buy-Side Research) CEO Investor VC/Corporate VC VC/Corporate VC Family Office Individual Investor Hedge/Mutual Funds (PM, Buy-Side Research) President, Biosciences Division Executive Co-Chair & CEO Capital Markets Associate VC/Corporate VC Financial Advising General Manager CEO Advisor President Head, Oncology R&D Chief Executive Officer Head, Oncology Commercial Strategy CEO VP of Investor Relations EVP Commercial Development CEO Executive Chairman Director, Life Sciences CEO SVP, Head of Corporate Communications VC/Corporate VC Venture Philanthropy CEO Chairman/CEO Vice President, Business Development CEO President/CSO Individual Investor President & CEO Hedge/Mutual Funds (PM, Buy-Side Research) VC/Corporate VC Senior business development advisor CEO Executive Director

EyeGate Pharmaceuticals EyeGate Pharmaceuticals Fannin Innovation Studio FC Capital First Island Capital First Seafront Fund Management First Wave FMG Ventures Fortress Biotech Fountain Healthcare Partners Foxhill Asset Management Franklin Global Partners Frigate Capital Management FSD Pharma FSD Pharma FSD Pharma Fujifilm Diosynth Biotechnologies Gagnon Securities Gain Therapeutics GBA Group Pharma Gedeon Richter Gedeon Richter USA Geistlich Pharma NA Geistlich Pharma North America Geistlich Pharma North America Gel4Med Genfit Pharmaceuticals Genfit SA Genfit SA Genisphere Georgia, USA Gero Global Blood Therapeutics Global Founders Capital Global Neurohealth Ventures Glycomine Glycostem Therapeutics Glysantis Glysantis Gnomegen Golden Eagle Capital Advisors Goldilocks Therapeutics Goldwater Asset Management Good Health Capital Government of Quebec Great Bay Bio Limited Greater Zurich Area Ag

United States United States United States United States United States China United States United States United States Ireland United States United States United States Canada Canada Canada United States United States Switzerland Austria United States United States United States United States United States United States United States France France United States United States Singapore United States United States United States United States Netherlands Canada Canada United States United States United States United States United States United States Hong Kong United States

VC/Corporate VC Chief Executive Officer VC/Corporate VC Senior Managing Director President & Head of Investment Banking Associate, Investment Banking Director, Healthcare Investment Banking Managing Director Managing Director, Investment Banking vice president Investment Bank Sell-Side Research VC/Corporate VC Venture Philanthropy VC/Corporate VC Family Office VC/Corporate VC Chief Medical Officer VP Finance Family Office Strategic Partner Family Office Royalty/Debt Financing VC/Corporate VC Royalty/Debt Financing VC/Corporate VC Family Office VC/Corporate VC Hedge/Mutual Funds (PM, Buy-Side Research) CEO Managing Director Royalty/Debt Financing Hedge/Mutual Funds (PM, Buy-Side Research) Venture Philanthropy VC/Corporate VC CEO Vice President CEO Senior Vice President Corporate Development President and CEO CEO EVP Chief Business Officer Chairman & CEO Chief Business Officer Director, Investor Relations & Communications Chief Financial Officer Hedge/Mutual Funds (PM, Buy-Side Research)

GreenSky Capital Greenwich LifeSciences Grey Sky Venture Partners Griffin Securities H.C. Wainwright & Company H.C. Wainwright & Company H.C. Wainwright & Company H.C. Wainwright & Company H.C. Wainwright & Company H.C. Wainwright & Company H.C. Wainwright & Company H.C. Wainwright & Company H.I.G. BioHealth Partners H.I.G. Capital Management H.I.G. Capital Management Hannol Ventures Harbin Pharmaceutical Group Harpoon Therapeutics Harpoon Therapeutics Harvard Investors Group Headland Strategy Group Health Innovative Technology HealthCare Royalty Partners HEDA Ventures Hercules Capital Hercules Capital Hibiscus Bioventures HighCape Capital Highland Capital Management Histogen Hitech Health Horizon Technology Finance Hudson East Capital Hudson Square Capital Hyperplane Ichor Biologics IDA Ireland Ilya Pharma Immunis.AI ImmunoMet Therapeutics Immunovant ImmunSYS ImmunSYS Impel NeuroPharma IMV IMV Inbio Ventures

Canada United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States China United States United States United States United States Hong Kong United States United States United States United States United States United States United States United States Ireland United States United States United States United States United States United States Sweden United States United States United States United States United States United States Canada Canada Russian Federation

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download